Researchers conducted a retrospective cohort study of 114 patients (68% female; median age at onset, 8.3 years; 92% White) with juvenile localized scleroderma from the National Registry for Childhood ...

Localized scleroderma, as the term denotes, is localized to the skin on the hands and face. It is characterized by slow progression and rarely transforms to the systemic type. Localized scleroderma is ...

Localized scleroderma is a rare connective tissue disorder characterized by hardening and thickening of the skin due to increased collagen density. A quarter of patients affected also experience ...

Disclosure: Kevin Deane, MD, has disclosed the following relevant financial relationships: Receiving grant funding from: NIH for the study of genetic and environmental factors that may influence the ...

Clinical enrollment for an open-label, single-arm Phase 1/2 trial of FCX-013 was initiated in August 2018. Fibrocell Science announced that the Food and Drug Administration (FDA) has granted Fast ...

Suggested Citation: "4 Scleroderma." National Academies of Sciences, Engineering, and Medicine. 2022. Selected Immune Disorders and Disability. Washington, DC: The ...

Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers is looking to change that. The group ...

Mycophenolate mofetil was equally effective and more tolerable than methotrexate for the treatment of juvenile localized scleroderma, according to a study published in JAMA Dermatology. Although ...

Find effective medications for 'Scleroderma treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...